Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial

References

• Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., … Taylor, D. (2010). Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science, 329, 1168–1174. doi:10.1126/science.1193748
   PubMed Web of Science ®Google Scholar
• Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., … Celum, C. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367, 399–410.
   PubMed Web of Science ®Google Scholar
• Carey, M. P., Carey, K., Maisto, S., Gordon, C., & Weinhardt, L. (2001). Assessing sexual risk behaviour with the Timeline Followback (TLFB) approach: Continued development and psychometric evaluation with psychiatric outpatients. International Journal of STD & AIDS, 12, 365–375. doi:10.1258/0956462011923309
   PubMed Web of Science ®Google Scholar
• Gafos, M., Mzimela, M., Ndlovu, H., Pool, R., Elford, J., & the MDP Team. (2012). What have men got to do with it?: The role of men in reproductive and sexual health in a predominantly rural area of KwaZulu-Natal, South Africa. Paper presented at the 2012 International Microbicides Conference, Sydney, Australia.
   Google Scholar
• Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363, 2587–2599. doi:10.1056/NEJMoa1011205
   PubMed Web of Science ®Google Scholar
• Greene, E., Batona, G., Hallad, J., Johnson, S., Neema, S., & Tolley, E. E. (2010). Acceptability and adherence of a candidate microbicide gel among high-risk women in Africa and India. Culture, Health & Sexuality, 12, 739–754. doi:10.1080/13691051003728599
   PubMed Web of Science ®Google Scholar
• MacQueen, K. M., Weaver, M. A., van Loggerenberg, F., Succop, S., Majola, N., Taylor, D., … Karim, S. A. (2014). Assessing adherence in the CAPRISA 004 tenofovir gel HIV prevention trial: Results of a nested case–control study. AIDS and Behavior, 18, 826–832. doi:10.1007/s10461-014-0753-8
   PubMed Web of Science ®Google Scholar
• Marrazzo, J., Ramjee, G., & Nair, G. (2013). Pre-exposure prophylaxis for HIV in women: Daily oral tenofovir, oral tenofovir/emtricitabine or vaginal tenofovir gel in the VOICE study (MTN 003). Paper presented at the 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA.
   Google Scholar
• McLellan-Lemal, E. (2008). Transcribing data for team-based research. In G. Guest & K. M. MacQueen (Eds.), Handbook for team-based qualitative research (p. 101). Lanham, MD: Altamira Pr.
   Google Scholar
• Mngadi, K. T., Maarschalk, S., Grobler, A. C., Mansoor, L. E., Frohlich, J. A., Madlala, B., … Karim, Q. A. (2014). Disclosure of microbicide gel use to sexual partners: Influence on adherence in the CAPRISA 004 trial. AIDS and Behavior, 18, 849–854. doi:10.1007/s10461-014-0696-0
   PubMed Web of Science ®Google Scholar
• Montgomery, C. M., Gafos, M., Lees, S., Morar, N. S., Mweemba, O., Ssali, A., … Team, T. M. (2010). Re-framing microbicide acceptability: Findings from the MDP301 trial. Culture, Health & Sexuality, 12, 649–662. doi:10.1080/13691051003736261
   PubMed Web of Science ®Google Scholar
• Montgomery, C. M., Lees, S., Stadler, J., Morar, N. S., Ssali, A., Mwanza, B., … Pool, R. (2008). The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care, 20, 733–740. doi:10.1080/09540120701693974
   PubMed Web of Science ®Google Scholar
• Montgomery, E. T., Cheng, H., van der Straten, A., Chidanyika, A. C., Lince, N., Blanchard, K., … Padian, N. S. (2010). Acceptability and use of the diaphragm and Replens® lubricant gel for HIV prevention in Southern Africa. AIDS and Behavior, 14, 629–638. doi:10.1007/s10461-009-9609-z
   PubMed Web of Science ®Google Scholar
• Morrow, K., Rosen, R., Richter, L., Emans, A., Forbes, A., Day, J., … Kelly, C. (2003). The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial. Journal of Women's Health, 12, 655–666. doi:10.1089/154099903322404302
   PubMed Web of Science ®Google Scholar
• Pistorius, A., van de Wijgert, J., Sebola, M., Friedland, B., Nagel, E., Bokaba, C., & Hoosen, A. (2004). Microbicide trials for preventing HIV/AIDS in South Africa: Phase II trial participants' experiences and psychological needs. SAHARA-J: Journal of Social Aspects of HIV/AIDS Research Alliance, 1(2), 78–86. doi:10.1080/17290376.2004.9724830
   PubMedGoogle Scholar
• Sahin-Hodoglugil, N. N., Montgomery, E., Kacanek, D., Morar, N., Mtetwa, S., Nkala, B., … van der Straten, A. (2011). User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa. AIDS Care, 23, 1026–1034.
   PubMed Web of Science ®Google Scholar
• Sahin-Hodoglugil, N. N., van der Straten, A., Cheng, H., Montgomery, E. T., Kacanek, D., Mtetwa, S., … Padian, N. (2006). Degrees of disclosure: A study of women's covert use of the diaphragm in an HIV prevention trial in sub-Saharan Africa. Social Science & Medicine, 69, 1547–1555. doi:10.1016/j.socscimed.2009.08.014
   Web of Science ®Google Scholar
• Thigpen, M., Kebaabetswe, P., Smith, D., Segolodi, T., Soud, F., Chillag, K., & Paxton, L. (2011). Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: Results from the TDF2 study. Paper presented at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome.
   Google Scholar
• Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., … Taylor, D. (2012). The FEM-PrEP trial of emtricitabine/tenofovir disoproxil fumarate (Truvada) among African women. Paper presented at the 19th Conference on Retroviruses and Opportunistic Infections, Seattle.
   Google Scholar
• van der Straten, A., Moore, J., Napierala, S., Clouse, K., Mauck, C., Hammond, N., & Padian, N. (2008). Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe. Contraception, 77, 435–443. doi:10.1016/j.contraception.2008.02.013
   PubMed Web of Science ®Google Scholar
• Woodsong, C., & Alleman, P. (2008). Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi. AIDS Education & Prevention, 20, 171–187. doi:10.1521/aeap.2008.20.2.171
   PubMed Web of Science ®Google Scholar
• Woodsong, C., MacQueen, K., Amico, K. R., Friedland, B., Gafos, M., Mansoor, L., … McCormack, S. (2013). Microbicide clinical trial adherence: Insights for introduction. Journal of the International AIDS Society, 16(1), 18505. doi:10.7448/IAS.16.1.18505
   PubMedGoogle Scholar